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Abstract We investigated the pharmacokinetics of caroverine in the perilymph, cerebrospinal fluid and plasma after
systemic and local administrations in guinea pigs by using high-performance liquid chromatography. Auditory brain⁃
stem responses were measured to evaluate auditory functional effect. The results showed that local application was a
both safe and efficient method. We further reviewed literature and pinpointed that the round window is effectively lo⁃
cal drug delivery means for future inner ear treatment.
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Introduction
The round window membrane（RWM） is located in
medial wall of the middle ear, within the round window
niche. The round window niche, which is posteroinferior
to the promontory, has a triangular shape and is bound
medially by the RWM［1］. There are commonly folds of
middle ear mucosa, which is termed false round window
membrane, at the entrance of the niche. The RWM sepa⁃
rates the niche from the scala tympani and its outer sur⁃
face is directly inferiorly. The cochlear aqueduct, which
connects the perilymphatic space with the cerebrospinal
space, is located close to the posterior part of the RWM.
The oval window is directly superior to the RWM.
The RWM is thicker at the edges and has a slight con⁃
vexity towards the scala tympani［2］. The average thick⁃
ness in human is 70 ?m and does not change with age.
The membrane consists of three layers: an outer epitheli⁃
um, a middle connective tissue, and an inner epithelium
［3］. The outer epithelium consists of a single layer of
cells continuous with the mucous membrane lining the
middle ear. The middle connective tissue contains fibro⁃
blasts, collagen, elastic fibers, and blood and lymph ves⁃
sels. It is the dominating part of the RWM and is
thought to be in conjunction with the mucoperiosteum of
the otic capsule. The inner epithelial cells are squamous
and consist of several layers of thin cells, which are con⁃
tinuous with the mesothelial cells of the scala tympani.
The extracellular spaces are large and no basal lamina
separates this layer from the middle fibrous layer.
The function of the RWM is presumed to release me⁃
chanical energy and/or conduct sound to the scala tym⁃
pani［4］. Based on experimental studies and anatomical
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observations, the RWM may also act as a barrier to oto⁃
toxic substances in the middle ear and participate in the
secretion and absorption of substances［5, 6］. Animal ex⁃
periments show that the RWM behaves like a semiper⁃
meable membrane. Many substances with both low and
high molecular weights have been demonstrated to pene⁃
trate through the RWM when placed in the round win⁃
dow niche［3, 7］. These substances include sodium ions,
antibiotics, antiseptics, arachidonic acid metabolites, lo⁃
cal anesthetics, toxins and albumin. Tracer studies us⁃
ing cationic ferritin, horseradish peroxidase, 1 μm latex
sphere and neomycin gold spheres have shown the per⁃
meability of the RWM to these substances when applied
in the middle ear side in chinchillas, guinea pigs, cats,
Mongolian gerbils, and rhesus monkeys. The permeabili⁃
ty of the RWM can be influenced by the factors such as
size, configuration, concentration, liposolubility and
electrical charge of the substance, and the thickness and
the condition of the RWM［8］. The substances placed on
the RWM may traverse through the cytoplasm as pinocy⁃
totic vesicles or through different channels in between
cells in the epithelium. In the connective tissue layer,
cells can phagocytize the substance and traverse to⁃
wards perilymph and/or penetrate blood or lymph ves⁃
sels in this layer［7］. Theoretically, after the substance
reaches the perilymph it would go towards the CSF
through the cochlear aqueduct, up to the scala tymphi,
or find way to the endolymph.
Local RWM application for the treatment of inner ear dis⁃
orders
Clinically, there is increasing interest in the local de⁃
livery of drugs directly into the inner ear across the in⁃
tact RWM. The main advantage of the local method is
that the drug will bypass the blood-labyrinth barrier and
directly enter the inner ear, resulting in higher inner ear
concentration and reduced systemic absorption and tox⁃
icity. In cases of Ménière's disease, the instillation of
gentamicin or streptomycin solutions into the middle ear
has been widely used as a method of suppressing vestib⁃
ular function in the affected ear［9］. This approach avoids
the risk of damaging the non-affected ear, as would oc⁃
cur with systemic treatments. Experimental studies are
developing uses for a wide variety of agents, including
steroids, local anesthetics, antioxidants, glutamate recep⁃
tor antagonists, neurotrophins and vectors for gene thera⁃
py, delivered on or through the RWM, as treatments for
various inner ear disorders ［9-14］. Furthermore,
several specific delivery systems have been developed
for more controlled local applications, including round
window microcatheter（Durect Inc., Cupertino, CA; In⁃
traEar, Inc., Denver, CO）, the MicroWick inserted
through a tympanic membrane vent tube into the round
window niche［15］, and a bone-anchored, totally implant⁃
able drug delivery system（TI-DDS）composed of a mi⁃
cropump, a drug reservoir and a septum port［16］.
However, most drug application protocols are empiri⁃
cally based because of the unknown pharmacokinetics
of the drugs in the inner ear. The amount and distribu⁃
tion of applied substances within the inner ear is poorly
understood due to the considerable technical difficulties
in making such measurements. As a result, the conse⁃
quences of changes in delivery method, applied drug
concentration, or even small alterations in treatment pro⁃
tocols have been difficult to predict. For instance, genta⁃
micin has been applied onto the RWM by single or re⁃
peated intratympanic injection, by application onto the
gelfoam placed on the RWM, by applying onto a wick, or
by continuous delivery via implanted catheters. The ther⁃
apeutic results varied significantly among these ap⁃
proaches［17］. The variation among different groups may
be attributable to both different dosing regimens and ap⁃
plication methods, although a correlation of outcome to
both dosage and application method has yet to be estab⁃
lished. The variability in results and the lack of unifor⁃
mity in treatment protocols make it important to investi⁃
gate the distribution and elimination of the drugs in the
cochlea fluid spaces and the influence of different meth⁃
ods of application.
Pharmacokinetics of caroverine in the inner ear and
its effects on the auditory function following local RWM
and systemic applications
There is growing interest in inner ear medication by
local routes instead of systemic application, in order to
achieve therapeutic drug levels in the inner ear while
avoiding undesirable systemic side effects. Caroverine,
as a glutamate receptor antagonist and an antioxidant in
combination with calcium channel blocking activity, is a
spasmolytic drug and also clinically used for the treat⁃
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ment of tinnitus, sudden hearing loss, speech discrimina⁃
tion disorders and other neurotoxic effects, such as isch⁃
emia/reperfusion, hypoglycemia, anoxia, hypoxia, shock
and dementia［18-20］. However, the risk of inducing un⁃
wanted side effects appears in most glutamate receptor
antagonists if given in large enough doses. Low doses
are associated with altered sensory perception, dyspho⁃
ria, hypertension, nystagmus and disorientation, with
progression to agitation, paranoia, hallucinations, severe
motor retardation and ultimately catatonia at higher dos⁃
es［21］. These potentially detrimental adverse effects obvi⁃
ously limit their clinical use for treatment of inner ear
diseases by systemic administration. Thus, it is impor⁃
tant to find alternative ways for the drug administration.
Delivery of agents into the inner ear via the RWM is
being increasingly used clinically. For instance, this ap⁃
proach has been utilized for the delivery of steroids and
gentamicin to the inner ear in the treatment of autoim⁃
mune diseases, sensorineural hearing loss, tinnitus and
Ménière’s disease［9, 15, 22-25］. Practically, this can be done
by insertion of a microcatheter system or a MicroWick
directly onto the RWM, or by using an implantable drug
delivery system, which results in a more controlled ap⁃
plication of the drugs ［15-16, 25］. An alternative method is
to instill the drugs via the tympanic membrane directly
into the middle ear using gelfoam on the RWM as a form
of continuous-release vehicle, which allows for pro⁃
longed drug perfusion of the labyrinth. This method is a
relatively simple and effective procedure that has been
used in both experimental and clinical studies［15, 22］. The
disadvantages of the method are that it is only one single
dose application and cannot apply the drug repeatedly.
The present study showed that by local applications
of caroverine onto the RWM with gelfoam, the peri⁃
lymph concentrations quickly reached high peak values
at 30 min, followed by a relatively fast decrease over
time. The perilymph peak values in the low dose（LD）
and high dose（HD）RWM groups were almost 20 and
80 times higher than the peak value reached in the sys⁃
temically group. As expected, the high dose produced
higher perilymph levels than the low dose, which sug⁃
gests that the absorption of caroverine through the RWM
is a dose-dependent process. The perilymph caroverine
concentration fell more slowly in the animals given the
drug directly onto the RWM than in those animals given
a much higher dose systemically. In the perilymph,
caroverine might be removed not only by passive diffu⁃
sion to endolymph or to the CSF through the cochlear aq⁃
ueduct, but also by active elimination such as blood flow
and lymphatic flow［26］. It is possible that the elimination
of caroverine is faster than what was shown in the two lo⁃
cal groups. The maintenance of caroverine concentration
in the perilymph in local groups is most likely due to the
continuous absorption of caroverine from the gelfoam
through the RWM. It is well known that the RWM is per⁃
meable to various drugs and substances placed in the
round window niche area. These include antibiotics, an⁃
tiseptics, arachidonic acid metabolites, local anesthet⁃
ics, toxins and albumin［7］ showing that not only small
molecules but also macromolecules can pass through the
RWM. Caroverine is a low-molecular-weight substance
（molecular weight of caroverine hydrochloride=420）and
should pass through the RWM quite freely. The concen⁃
trations of caroverine in the perilymph after local appli⁃
cations were considerably higher than those found fol⁃
lowing systemic application. These results clearly illus⁃
trated the permeability of the RWM to caroverine. Con⁃
sequently, high concentrations of caroverine can be at⁃
tained in the perilymph by application of a small amount
of the drug on the RWM.
After systemic administration, the concentrations of
caroverine in the plasma were consistently higher than
those in the CSF and perilymph. This can be attributed
to the existences of both blood-brain and blood-laby⁃
rinth barriers. The perilymph concentrations seemed to
be higher than CSF concentrations, but the difference
was not statistically significant. This may reflect the dif⁃
ferences between the blood-brain barrier and blood-lab⁃
yrinth barrier, or the properties of the communication be⁃
tween the CSF and perilymph through the cochlear aque⁃
duct. Another important observation, although not entire⁃
ly unexpected, was that local caroverine applications re⁃
sulted in much lower drug concentrations in the plasma
and CSF as compared to systemic administration. For ex⁃
ample, the plasma and CSF caroverine peak values in
the systemically group were about 12 and 6 times the
peak values in the HD group, respectively. A less sys⁃
temic adverse effect may be expected with the lower
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caroverine concentrations in plasma and CSF. This is in
part related to the dose. The total volume of the peri⁃
lymph is only around 15.9 mm? in the guinea pig cochlea
［27］. Therein lies the major advantage of the RWM admin⁃
istration, which is the ability to achieve a high local
drug concentration without high blood and CSF levels.
The ideal concentration of caroverine in the peri⁃
lymph for the treatment of inner ear diseases, such as
tinnitus, remains unknown. In this study, the intrave⁃
nous dose used in guinea pigs was the same as that used
clinically in the treatment of tinnitus. Assuming similar
pharmacokinetics in guinea pigs and humans, one may
presume the therapeutic concentration of caroverine to
be around 0.2-0.3μg/ml in the perilymph, which was
the peak caroverine concentration in the perilymph after
systemic administration in the present study. The two
dosages for RWM applications were chosen somewhat ar⁃
bitrarily. However, the main purpose of the study was
not to establish a therapeutic window but to relate the
auditory effects to caroverine concentrations in the peri⁃
lymph. The effects on hearing threshold were tested by
measuring the ABR to sound stimuli following local
caroverine applications. The perilymph caroverine con⁃
centration is expected to be higher in the basal, high fre⁃
quency region of the cochlea, being closer to the RWM.
Indeed, the maximum changes in the ABR threshold, la⁃
tency and amplitude occurred at 20 kHz at 30 min after
applications in both local administration groups, and the
changes were all statistically significant. The ABR was
less affected at the frequencies of 16, 12.5 and 8 kHz,
most likely due to the lower caroverine concentrations at
positions further from the RWM. The ABR thresholds re⁃
covered partially at 3 and 6 h and were completely back
to normal levels 24 h after administration. The two local
dosages caused transient, but reversible hearing dysfunc⁃
tion. The hearing dysfunction may be due to the reason
that caroverine binds to both NMDA and AMPA recep⁃
tors, thus blocking the activity of the neurotransmitter
glutamate and consequently the transduction of the
sound. As the transient dysfunction is dose related, one
would expect it to be negligible at the assumed therapeu⁃
tic concentration, which is much lower than the peri⁃
lymph concentration after RWM application in the
study. The slight hearing impairment seen in the control
group was most likely due to the weight of gelfoam and
saline on the RWM, surgical stress and possibly an al⁃
tered ionic balance as sodium and chloride ions will en⁃
ter the perilymph when saline is applied on the RWM
［28-30］.
By combining the pharmacokinetic observations with
the changes seen in the ABR thresholds in the HD
group, it is clearly demonstrated that the ABR effect was
related to the concentration of caroverine in the peri⁃
lymph.
Further studies are necessary to find out the ideal
dose and administration paradigm. The study of the ef⁃
fect following local applications of caroverine on the
RWM in the treatment of excitotoxicity-related inner
ear diseases, such as noise-induced hearing loss, can be
carried out on the animal models. This information will
be useful for the establishment and formulation of the lo⁃
cal application method in the clinic in the future.
Protection of auditory function against noise trauma
This part of study demonstrated that local caroverine
administrations directly onto the RWM immediately pri⁃
or to noise exposure produced significant protection of
auditory function against noise. The protective effect
was dose-dependent, with greater effect in the HD
group than in the LD group. The significant protection,
as measured by using the ABR threshold, was found at
24 h, 3 days and 1 week after noise exposure at all test⁃
ed frequencies（4-20 kHz）. These results support the
notion that pharmacological protection of cochlear func⁃
tion has a promising potential for the prevention of
noise-induced hearing impairment.
Glutamate receptor antagonists, such as MK-801 and
kynurenic acid, have been shown to be effective in the
protection of neuronal dendrite damage beneath the
IHCs against noise trauma and consequently to preserve
hearing［31-33］. During noise exposure, it appears that AM⁃
PA receptors are activated by low-to-moderate stimulus
intensities, whereas NMDA receptors are activated by
high-intensity sounds［34］. In our experiments, noise ex⁃
posure at 110 dB SPL would have activated both NMDA
and AMPA receptors. Our results suggest that the
NMDA and AMPA receptors on the afferent dendrites
are being blocked by their antagonist caroverine, thus
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the glutamate excitotoxicity due to noise exposure is lim⁃
ited and the cochlear functional damage is prevented.
Another possible explanation to the protection of audi⁃
tory function against noise trauma may be based on the
antioxidant activity of caroverine. Glutamatergic neuro⁃
toxicity is partially caused by the overproduction of ROS
and following membrane damage by lipid peroxidation
［35-36］. The accumulating evidences show that ROS play
an important role in NIHL. Ohlemiller et al.［37］dem⁃
onstrated that ROS increased nearly 4-folds in the co⁃
chlea during the first 1-2 h after intense noise exposure
and did not decrease over that time. ROS were shown to
affect the isolated OHC morphology or impair cochlear
function after perilymphatic space infusion［38-39］. A vari⁃
ety of antioxidants such as superoxide dismutase-polyth⁃
ylene glycol and allopurinol could protect cochlear dam⁃
age when applied prior to noise exposure［40］. Caroverine
is a strong antioxidant as demonstrated recently by
Udilova et al.［41］. They found that the antioxidant activi⁃
ty of caroverine was not only the potent removal of
OH.-radicals but also the ability to interfere into
OH.-radical generation and thus to inhibit the establish⁃
ment of oxidative stress. Consequently, it is reasonable
to expect caroverine to prevent ROS toxicity to the co⁃
chlea after noise exposure.
The protection of cochlea from noise trauma might al⁃
so due to the calcium channel blocking activity of
caroverine. Four types of voltage-activated calcium
channels have been identified in various cell mem⁃
branes: N, T, P and L type calcium channels［42-43］. The
L-type channel（slow inactivation and susceptibility to
the dihydropyridine class of blockers, such as nimodip⁃
ine）has been demonstrated to be present in the mamma⁃
lian inner ear tissues with molecular biological studies
［44-46］. It has been found that the L-type channel is the
only channel type present in the chick cochlear hair
cells ［47］. However, the presence of at least of one other
type（possibly N-type）in addition to L-type channels
has been suggested［48-49］. The calcium channels have
been shown to play important roles in controlling neu⁃
rotransmitter release from the hair cells which are impor⁃
tant in regulating excitation of the auditory nerve fibers
［45-46, 50-53］. In addition, voltage-gated calcium channels
can regulate the conductance of the basolateral wall of
the hair cells mainly through the action of calcium-acti⁃
vated potassium channels ［51, 54-55］ and may also contrib⁃
ute to the regulation of other calcium-dependent as⁃
pects of hair cell fuction, including adaptation and slow
contractile processes［56-58］. In the guinea pig, it has been
demonstrated that L-type calcium channels are involved
in the various aspects of cochlear response to sound and
in the transmitter release from the IHCs［59-60］. Intense
noise exposure might disturb the hair cell metabolism,
especially the calcium-regulatory processes. The al⁃
tered calcium concentration in the inner hair cells might
increase the neurotransmitter release and induce excito⁃
toxicity. Thus, calcium antagonists would be able to pro⁃
tect the cochlea from noise trauma. In fact, certain calci⁃
um channel blockers, such as diltiazem, have been
shown to protect the inner and outer hair cells from in⁃
tense noise exposure in the guinea pig［61-63］. However,
some other studies showed that calcium channel block⁃
ers, for instance, nimodipine and diltiazem, could not
provide any benefit effect against noise trauma in the
gerbil, mouse or human. This may be due to the different
dosing protocols or different expression of calcium chan⁃
nels in the cochleae in different species. Caroverine has
unspecific calcium channel blocking activity. The pro⁃
tective effect of caroverine against noise trauma might
partly be contributed to its blocking of calcium channels
in the hair cells, preventing calcium influx into the hair
cells. This might prevent the damage of excessive calci⁃
um to the hair cells and also reduced the over-release of
excitatory neurotransmitter from inner hair cells and
thus decreased the excitotoxicity.
Our previous study demonstrated that caroverine
readily penetrated the RWM in the guinea pig ［64］.
Caroverine concentration in the perilymph reached its
peak value at 30 min after both low and high dose local
applications with gelfoam. In the LD group, caroverine
became undetectable in the perilymph within 6 h, while
in the HD group caroverine still remained at a high level
at 6 h after RWM application. The effect on hearing was
mainly seen at the higher frequencies（i.e., closer to the
round window）. At 30 min there was a 56 dB threshold
shift at 20 kHz, which recovered partially at 3 and 6 h.
Thresholds became normal at 24 h. The present study
shows that caroverine can effectively protect the
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cochlear function against noise trauma when applied
immediately prior to noise exposure. Within the first 6 h
after RWM applications, there was no significant
difference in threshold shift between the LD or HD
group and control group. This is most likely due to high
concentration of caroverine in the perilymph binding to
the glutamate receptors, thus blocking the effect of the
neurotransmitter （glutamate） and the sound
transduction. However, at 24 h after caroverine
application, there was a significant decrease in
noise-induced threshold shifts. In addition, the HD
group, with a higher caroverine concentration in the
perilymph, as shown previously［64］ maintained greater
protective effect as compared to the LD group. The
protection was still manifest 1 week after caroverine
application.
The frequency effect observed in this study is of
particular interest. The protective effect is of the most
significance at 20 kHz. This could be attributed to the
higher concentration of caroverine in the basal, high
frequency region of the cochlea, being closer to the
RWM. After noise exposure, there was a more severe
threshold elevation at 8 kHz, which is compatible to the
well-known phenomenon of‘half-octave shift’ in a
damage cochlea［65-66］. According to the half-octave shift,
the most vulnerable frequency is around 9 kHz when
exposed to 6.3 kHz band noise.
However, the auditory threshold did not recover
completely to normal level even at 1 week after
caroverine application in the HD group. There were still
10-15 dB threshold shifts at 20, 16, 12.5 and 4 kHz,
and 30 dB at 8 kHz. Glutamate receptor antagonists
other than caroverine, including NMDA or AMPA
receptor antagonists, only partially protect the cochlear
function against auditory impairment［31-32, 67-69］. This may
be partially due to the incomplete reestablishment of the
hair cell neural synaptic contacts. That glutamate
receptor antagonists do not completely protect against
NIHL reflects the fact that other mechanisms are also
involved. Two main mechanisms are proposed to be
involved in NIHL: mechanical damage, which is
permanent and irreversible, and metabolic alterations.
Damage to the OHC is thought to be especially
important for NIHL based on the histological studies
using surface preparation［70-72］. Glutamate receptors are
demonstrated to be present mainly on the spiral ganglion
cell and sparely on the IHCs and be absent on the
OHCs, although glutamate receptor expressions are
transiently presented on the OHCs in the developing ear
［73-76］.
The cellular and molecular mechanisms underlying
hearing loss are not well known. The impairment of the
inner ear after noise trauma may involve
glutamate-mediated excitotoxicity, oxidative stress,
apoptosis of hair cells and auditory neurons ［77-80］,
unregulated calpain proteolysis［83-84］and the decrease of
the microcirculation of the cochlea［85］. Different agents
have been applied to interfere these pathways for the
protection of cochlea against noise trauma. Wang et al.
demonstrated that the anti-apoptosis agent riluzole
could prevent the noise-induced permanent hearing loss
when perfused into the cochlea via an osmotic
minipump in the guinea pig［81］. The calpain inhibitor
leupeptin has been shown to significantly protect the
cochlea from noise trauma［82, 86］. Lamm and Arnold found
that the blood flow promoting drugs, such as
hydroxyethyl starch, pentoxifylline and ginkgo biloba,
could compensate cochlear ischemia and reduce
noise-induced hearing loss［87］. Neurotrophins, including
nerve growth factor（NGF）, brain-derived nerve growth
factor（BDNF）, neurotrophin-3（NT-3） and glial cell
line-derived neurotrophic factor（GDNF）, are known to
play a role in the survival of injured auditory neurons［88］.
The protective effects of the neurotrophins against noise
trauma have been widely studied. Numerous reports
have shown that neurotrophins, such as NT-3, BDNF,
GDNF and NGF, could protect the auditory neurons and
hair cells from noise trauma ［32, 89-90］. Since these agents
protect the cochlea from noise-induced hearing loss by
different mechanisms, it might be more promising to
combine caroverine with these agents to protect the
cochlea from noise trauma.
In conclusion, the result of this part of study
demonstrates that caroverine can significantly protect
the cochlea from noise trauma when applied onto the
RWM immediately prior to noise exposure. The
protective effect of caroverine, an NMDA and AMPA
receptor antagonist together with antioxidant and
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calcium channel blocking activities, against noise notion
that the excessive release of glutamate from the IHCs
and the consequent excessive ROS production plays an
important role in the pathophysiology of NIHL. Thus,
pharmacological protection of the cochlea against noise
is possible and may be of great clinical potential.
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